ZYXI - I own a small portion right now, I had sold all of it on the run-up into the $20s, then I repurchased a small bit around $15. If they continue to execute and grow I think they will be in great position but COVID has slowed them down.
69% revenue growth 96% order growth 9/30/2020 ending quarter
77% revenue growth 76% order growth 6/30/2020 ending quarter
66% revenue growth 126% order growth 3/31/2020 ending quarter
Order growth (the leading indicator) took a step back in the 6/30 ending quarter, then started moving again. That caused revenue growth to slow again. With COVID it has been harder for salespeople to get access to doctors in order to sell. However, it has also made it easy to hire people, so they have been hiring salespeople at an accelerated pace. Revenues I think will continue to trend upward caused by all the new salespeople hired and because order growth has already turned back up. However, these salespeople are all dedicated and on a partial salary, so that is depressing the bottom the bottom line. So I think revenues will move up and bottom line will remain depressed for another few quarters, but at some point the bottom line will catch up. In a couple years I think they will have huge profits, but I'm not sure when the bottom line starts to turn up again.
Some people think they are hiring all these people to cover up declining growth or declining demand. They also added a catalog of other generic products to sell, and some people think that was out of desperation. I don't see those things.
They have a blood volume monitor that is ready to go, but they are building a separate sales team for that. My impression is that will take a long time to develop and won't give them profits in the near term, but only drive costs.
News 
Market Data 
Discover 
